{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A disease and management insight survey among healthcare practitioners on urticaria in India

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What is the percentage of urticaria patients out of total patients you see in your clinic? *

  2. What is the most common suspected cause behind urticaria? *

  3. Out of total urticaria patients you see, what % of such patients are acute and chronic *
    4. Acute urticaria
    %
    Chronic urticaria
    %
  4. Out of total patients of chronic urticaria, what % of such patients have chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CINDU) *
    5. CSU
    %
    CINDU
    %
  5. Out of total CSU patients you see, what % are in mild, moderate or severe grade of CSU? *
    6. Mild
    %
    Moderate
    %
    Severe
    %
  6. In your experience, who is more commonly affected by CSU? *

  7. What percentage of patients suffering from urticaria miss their work (affect QOL)? *

  8. What percentage of CSU patients had association with other autoimmune disease? *

  9. Which autoimmune disease having common association with CSU? *
  10. What are the common symptoms associated with CSU patients? *
  11. What is the average duration of symptoms in CSU patients? *

  12. What % of CSU patients have associated angioedema as well? *

  13. Initial diagnosis of CSU is based on *
  14. Which laboratory investigations due you suggest in your patients with CSU? *
  15. What percentage of CSU patients get resolved within one year? *

  16. In patients with severe CSU, what is your line of treatment? *

  17. How long do you wait before up titrating dose of antihistamine in patients with CSU? *

  18. What percentage of refractory patients respond to up dosing of antihistamines? *

  19. Which is your preferred antihistamine in CSU? (Kindly rank considering 1 being the most preferred and 4 being the least preferred) *
    20. Levocetirizine
    Desloratadine
    Fexofenadine
    Bilastine
  20. What percentage of CSU patients respond to standard dose of levocetirizine (5 mg)? *

  21. What percentage of CSU patients who are refractory to the standard dose of levocetirizine, respond to the up dosing (10-20 mg of levocetirizine)? *

  22. In addition to 2nd generation anti-histamins do you prescribe any other drugs in your patients with CSU? *

  23. In what percentage of patients with CSU do you have to add corticosteroids? *

  24. How long do you recommend to take corticosteroids? *

  25. In what percentage of your patients with CSU, do you recommend cyclosporine? *

  26. In what percentage of your patients with CSU, do you recommend Omalizumab? *

  27. Do you think there is a role of montelukast in management of CSU? *

  28. If yes, to Q. 27, do you prefer to use fixed dose combination (FDC) of montelukast with antihistamine or you add montelukast separately to antihistamine?
  29. What percentage of CSU patients are unhappy about the treatments currently available. *

  30. How do you assess response to treatment in your patients? *
  31. Which second-generation anti-histamine do you prefer in pregnant females? *
  32. Do you up dose second-generation anti-histamine in pregnant females *

  33. Which second-generation anti-histamine do you prefer in lactation? *
  34. Which second-generation anti-histamine do you prefer in patients with hepatic impairment? *
  35. Which second-generation anti-histamine do you prefer in patients with renal impairment? *